{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:02:01Z","timestamp":1793746921906,"version":"4.6.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["seminoncol.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1053\/j.seminoncol.2016.09.001","type":"journal-article","created":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T15:19:32Z","timestamp":1474557572000},"page":"566-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Genetic predisposition to kidney cancer"],"prefix":"10.1053","volume":"43","author":[{"given":"Laura S.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Marston","family":"Linehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2016.09.001_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib2","first-page":"521","article-title":"Genetic analysis of von Hippel-Lindau disease","volume":"31","author":"Nordstrom-O\u2019Brien","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib3","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0022-5347(01)66674-6","article-title":"Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications","volume":"154","author":"Walther","year":"1995","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib4","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0022-5347(05)68930-6","article-title":"Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery","volume":"161","author":"Walther","year":"1999","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib5","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/nar\/26.1.256","article-title":"Software and database for the analysis of mutations in the VHL gene","volume":"26","author":"B\u00e9roud","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0594-85","article-title":"Mutations of the VHL tumour suppressor gene in renal carcinoma","volume":"7","author":"Gnarra","year":"1994","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib8","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1158\/1078-0432.CCR-07-4921","article-title":"Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors","volume":"14","author":"Nickerson","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib9","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1126\/science.7660122","article-title":"Inhibition of transcription elongation by the VHL tumor suppressor protein","volume":"269","author":"Duan","year":"1995","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib10","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.7660130","article-title":"Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C","volume":"269","author":"Kibel","year":"1995","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib11","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1073\/pnas.94.6.2156","article-title":"The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins","volume":"94","author":"Pause","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1126\/science.284.5414.657","article-title":"Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase","volume":"284","author":"Kamura","year":"1999","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib15","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","article-title":"Hypoxia-inducible factors and the response to hypoxic stress","volume":"40","author":"Majmundar","year":"2010","journal-title":"Mol Cell"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1758834010361470","article-title":"Updates on novel therapies for metastatic renal cell carcinoma","volume":"2","author":"Courtney","year":"2010","journal-title":"Ther Adv Med Oncol"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-5347(17)35015-2","article-title":"Hereditary papillary renal cell carcinoma","volume":"151","author":"Zbar","year":"1994","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9440(10)65147-4","article-title":"Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype","volume":"155","author":"Lubensky","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0022-5347(05)67893-7","article-title":"Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer","volume":"163","author":"Ornstein","year":"2000","journal-title":"J Urol"},{"issue":"4 Pt 1","key":"10.1053\/j.seminoncol.2016.09.001_bib21","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/01.ju.0000139583.63354.e0","article-title":"Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene","volume":"172","author":"Schmidt","year":"2004","journal-title":"J Urol"},{"issue":"8","key":"10.1053\/j.seminoncol.2016.09.001_bib22","first-page":"1719","article-title":"Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene","volume":"58","author":"Schmidt","year":"1998","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1148\/radiol.2261011296","article-title":"Hereditary renal cancers","volume":"226","author":"Choyke","year":"2003","journal-title":"Radiology"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib24","first-page":"658767","article-title":"Familial renal cancer: molecular genetics and surgical management","volume":"2011","author":"Barrisford","year":"2011","journal-title":"Int J Surg Oncol"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0597-68","article-title":"Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas","volume":"16","author":"Schmidt","year":"1997","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib26","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1038\/sj.onc.1202547","article-title":"Novel mutations of the MET proto-oncogene in papillary renal carcinomas","volume":"18","author":"Schmidt","year":"1999","journal-title":"Oncogene"},{"issue":"8","key":"10.1053\/j.seminoncol.2016.09.001_bib27","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2174\/1566524043359674","article-title":"Hereditary papillary renal carcinoma type I","volume":"4","author":"Dharmawardana","year":"2004","journal-title":"Curr Mol Med"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib28","doi-asserted-by":"crossref","first-page":"12654","DOI":"10.1073\/pnas.1734128100","article-title":"Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a","volume":"100","author":"Schiering","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib29","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1073\/pnas.94.21.11445","article-title":"Activating mutations for the met tyrosine kinase receptor in human cancer","volume":"94","author":"Jeffers","year":"1997","journal-title":"Proc Natl Acad Sci U SA"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2559.1993.tb00061.x","article-title":"Molecular differential pathology of renal cell tumours","volume":"22","author":"Kovacs","year":"1993","journal-title":"Histopathology"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib31","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/1727","article-title":"Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas","volume":"20","author":"Zhuang","year":"1998","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal cell carcinoma","volume":"374","author":"Cancer Genome Atlas Research Network","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2012.43.3383","article-title":"PhaseII and biomarker study of the dual MET\/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma","volume":"31","author":"Choueiri","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib34","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1001\/archderm.1977.01640120042005","article-title":"Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons","volume":"113","author":"Birt","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib35","first-page":"393","article-title":"Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dub\u00e9 syndrome","volume":"11","author":"Zbar","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib36","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1086\/430842","article-title":"Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dub\u00e9 syndrome","volume":"76","author":"Schmidt","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib37","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archderm.135.10.1195","article-title":"Birt-Hogg-Dub\u00e9 syndrome: a novel marker of kidney neoplasia","volume":"135","author":"Toro","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/jmg.2007.054304","article-title":"BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dub\u00e9 syndrome: a new series of 50 families and a review of published reports","volume":"45","author":"Toro","year":"2008","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib39","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/00000478-200212000-00002","article-title":"Renal tumors in the Birt-Hogg-Dub\u00e9 syndrome","volume":"26","author":"Pavlovich","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib40","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10689-013-9657-4","article-title":"Diagnosis and management of BHD-associated kidney cancer","volume":"12","author":"Stamatakis","year":"2013","journal-title":"Fam Cancer"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib41","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S1470-2045(09)70188-3","article-title":"Birt-Hogg-Dub\u00e9 syndrome: diagnosis and management","volume":"10","author":"Menko","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1535-6108(02)00104-6","article-title":"Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dub\u00e9 syndrome","volume":"2","author":"Nickerson","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib43","doi-asserted-by":"crossref","first-page":"E1043","DOI":"10.1002\/humu.21130","article-title":"A new locus-specific database (LSDB) for mutations in the folliculin (FLCN) gene","volume":"31","author":"Lim","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib44","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jnci\/dji154","article-title":"High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dub\u00e9-associated renal tumors","volume":"97","author":"Vocke","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib45","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1476-4598-9-160","article-title":"Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling","volume":"9","author":"Hong","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib46","doi-asserted-by":"crossref","first-page":"15552","DOI":"10.1073\/pnas.0603781103","article-title":"Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling","volume":"103","author":"Baba","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.gene.2008.02.022","article-title":"Identification and characterization of a novel folliculin-interacting protein FNIP2","volume":"415","author":"Hasumi","year":"2008","journal-title":"Gene"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib48","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nat Cell Biol"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib49","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/jnci\/djm288","article-title":"Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1\/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys","volume":"100","author":"Baba","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib50","doi-asserted-by":"crossref","first-page":"e3581","DOI":"10.1371\/journal.pone.0003581","article-title":"Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia","volume":"3","author":"Chen","year":"2008","journal-title":"PLoS One"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib51","doi-asserted-by":"crossref","first-page":"18722","DOI":"10.1073\/pnas.0908853106","article-title":"Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2","volume":"106","author":"Hasumi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib52","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/jmg.2009.072009","article-title":"Renal tumour suppressor function of the Birt-Hogg-Dub\u00e9 syndrome gene product folliculin","volume":"47","author":"Hudon","year":"2010","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib53","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/onc.2009.14","article-title":"The role of the Birt-Hogg-Dub\u00e9 protein in mTOR activation and renal tumorigenesis","volume":"28","author":"Hartman","year":"2009","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib54","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrurol.2015.206","article-title":"Molecular genetics and clinical features of Birt-Hogg-Dub\u00e9 syndrome","volume":"12","author":"Schmidt","year":"2015","journal-title":"Nat Rev Urol"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib55","first-page":"503","article-title":"A case of metastatic renal cell carcinoma associated with Birt-Hogg-Dub\u00e9 syndrome treated with molecular-targeting agents [Japanese]","volume":"59","author":"Nakamura","year":"2013","journal-title":"Hinyokika Kiyo"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib56","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/376435","article-title":"Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America","volume":"73","author":"Toro","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1399-0004.2010.01486.x","article-title":"Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis","volume":"79","author":"Smit","year":"2011","journal-title":"Clin Genet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jmg.2005.033506","article-title":"Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer","volume":"43","author":"Wei","year":"2006","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib59","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/jmg.2010.085068","article-title":"Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma","volume":"48","author":"Gardie","year":"2011","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib60","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.juro.2007.01.155","article-title":"Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer","volume":"177","author":"Grubb","year":"2007","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib61","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib62","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10689-009-9306-0","article-title":"Hereditary leiomyomatosis and renal cell carcinoma: very early diagnosis of renal cancer in a paediatric patient","volume":"9","author":"Alrashdi","year":"2010","journal-title":"Fam Cancer"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib63","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1073\/pnas.051633798","article-title":"Inherited susceptibility to uterine leiomyomas and renal cell cancer","volume":"98","author":"Launonen","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib64","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib65","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2350-9-20","article-title":"The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency","volume":"9","author":"Bayley","year":"2008","journal-title":"BMC Med Genet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib66","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/hmg\/ddg148","article-title":"Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency","volume":"12","author":"Alam","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib67","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/jmg.2006.041087","article-title":"Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer","volume":"43","author":"Pithukpakorn","year":"2006","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib68","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","article-title":"HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability","volume":"8","author":"Isaacs","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib69","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","article-title":"Accumulation of Krebs cycle intermediates and over-expression of HIF1\u03b1 in tumours which result from germline FH and SDH mutations","volume":"14","author":"Pollard","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib70","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ccr.2011.07.018","article-title":"The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels","volume":"20","author":"Tong","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib71","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature10642","article-title":"Reductive carboxylation supports growth in tumour cells with defective mitochondria","volume":"481","author":"Mullen","year":"2011","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2006.03.005","article-title":"S-(2-succinyl)cysteine: a novel chemical modification of tissue proteins by a Krebs cycle intermediate","volume":"450","author":"Alderson","year":"2006","journal-title":"Arch Biochem Biophys"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib73","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ccr.2011.09.006","article-title":"Renal cyst formation in Fh1-deficient mice is independent of the Hif\/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling","volume":"20","author":"Adam","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib74","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ccr.2011.08.024","article-title":"An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma","volume":"20","author":"Ooi","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib75","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.redox.2012.10.001","article-title":"The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer","volume":"1","author":"Kansanen","year":"2013","journal-title":"Redox Biol"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib76","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ccell.2014.10.005","article-title":"Targeting ABL1-mediated oxidative stress adaptation in fumarate hydratase-deficient cancer","volume":"26","author":"Sourbier","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib77","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/381054","article-title":"Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma","volume":"74","author":"Vanharanta","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib78","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/djn254","article-title":"Germline SDHB mutations and familial renal cell carcinoma","volume":"100","author":"Ricketts","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib79","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.juro.2012.08.030","article-title":"Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer","volume":"188","author":"Ricketts","year":"2012","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib80","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1530\/ERC-11-0324","article-title":"Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3","volume":"19","author":"Malinoc","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib81","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1053\/j.seminoncol.2016.09.001_bib82","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv287","article-title":"SDHB-deficient cancers: the role of mutations that impair iron sulfur cluster delivery","volume":"108","author":"Saxena","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib83","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N Eng J Med"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib84","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","author":"European Chromosome 16 Tuberous Sclerosis Consortium","year":"1993","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib85","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib86","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib87","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc3459","article-title":"BAP1 and cancer","volume":"13","author":"Carbone","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib88","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","author":"Pena-Llopis","year":"2012","journal-title":"Nat. Genet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib89","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib90","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","article-title":"Germline BAP1 mutations predispose to renal cell carcinomas","volume":"92","author":"Popova","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib91","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1158\/1541-7786.MCR-13-0111","article-title":"A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma","volume":"11","author":"Farley","year":"2013","journal-title":"Mol Cancer Res"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib92","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cge.12630","article-title":"Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases","volume":"89","author":"Rai","year":"2016","journal-title":"Clin Genet"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib93","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejcb.2013.10.002","article-title":"A germline oncogenic MITF mutation and tumor susceptibility","volume":"93","author":"Bressac-de-Paillerets","year":"2014","journal-title":"Eur J Cell Biol"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib94","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature10539","article-title":"A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma","volume":"480","author":"Bertolotto","year":"2011","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib95","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature10630","article-title":"A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma","volume":"480","author":"Yokoyama","year":"2011","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib96","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/pcmr.12047","article-title":"Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history","volume":"26","author":"Ghiorzo","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib97","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1097\/01.ju.0000096060.92397.ed","article-title":"The genetic basis of cancer of the kidney","volume":"170","author":"Linehan","year":"2003","journal-title":"J Urol"},{"key":"10.1053\/j.seminoncol.2016.09.001_bib98","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775416300744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775416300744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T18:27:11Z","timestamp":1568399231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775416300744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":98,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0093775416300744"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2016.09.001","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic predisposition to kidney cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminoncol.2016.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}